CNXC CONCENTRIX CORP revenue, earnings and financials
For the quarter ended August 31, 2026, CONCENTRIX CORP reported revenue of $2.45B (down 1.2% from a year earlier), net income of −$988M and diluted EPS of −$16.24; over the last four quarters revenue was $9.97B and net income −$2.39B; for the fiscal year ended November 2025 revenue was $9.83B, up 2.2% on the year before.
CNXC annual revenue and earnings
- Fiscal year ended Nov 2025: revenue $9.83B, gross profit $3.44B, operating income −$918M, net income −$1.28B (margin -13.0%), EPS −$20.36
- Fiscal year ended Nov 2024: revenue $9.62B, gross profit $3.45B, operating income $596M, net income $251M (margin 2.6%), EPS $3.71
- Fiscal year ended Nov 2023: revenue $7.11B, gross profit $2.58B, operating income $661M, net income $314M (margin 4.4%), EPS $5.70
- Fiscal year ended Nov 2022: revenue $6.32B, gross profit $2.26B, operating income $640M, net income $435M (margin 6.9%), EPS $8.28
- Fiscal year ended Nov 2021: revenue $5.59B, gross profit $1.97B, operating income $572M, net income $406M (margin 7.3%), EPS $7.70
CNXC quarterly revenue and earnings
- Quarter ended Aug 31, 2026: revenue $2.45B (down 1.2% year over year), net income −$988M, EPS −$16.24
- Quarter ended May 31, 2026: revenue $2.46B (up 1.9% year over year), net income $55.3M, EPS $0.86
- Quarter ended Feb 28, 2026: revenue $2.50B (up 5.4% year over year), net income $21.6M, EPS $0.33
- Quarter ended Nov 30, 2025 (from the annual report): revenue $2.55B (up 4.3% year over year), net income −$1.48B, EPS −$23.37
- Quarter ended Aug 31, 2025: revenue $2.48B (up 4.0% year over year), net income $88.1M, EPS $1.34
- Quarter ended May 31, 2025: revenue $2.42B (up 1.5% year over year), net income $42.1M, EPS $0.63
- Quarter ended Feb 28, 2025: revenue $2.37B (down 1.3% year over year), net income $70.3M, EPS $1.04
- Quarter ended Nov 30, 2024 (from the annual report): revenue $2.45B (up 9.7% year over year), net income $116M, EPS $1.72
- Quarter ended Aug 31, 2024: revenue $2.39B (up 46.2% year over year), net income $16.6M, EPS $0.25
- Quarter ended May 31, 2024: revenue $2.38B (up 47.4% year over year), net income $66.8M, EPS $0.98
- Quarter ended Feb 29, 2024: revenue $2.40B (up 46.8% year over year), net income $52.1M, EPS $0.76
- Quarter ended Nov 30, 2023 (from the annual report): revenue $2.23B (up 36.0% year over year), net income $69.5M, EPS $1.02
- Quarter ended Aug 31, 2023: revenue $1.63B (up 3.4% year over year), net income $77.6M, EPS $1.49
- Quarter ended May 31, 2023: revenue $1.61B (up 3.0% year over year), net income $78.9M, EPS $1.51
- Quarter ended Feb 28, 2023: revenue $1.64B (up 6.5% year over year), net income $87.9M, EPS $1.68
- Quarter ended Nov 30, 2022 (from the annual report): revenue $1.64B (up 11.9% year over year), net income $105M, EPS $2.01
- Quarter ended Aug 31, 2022: revenue $1.58B (up 13.1% year over year), net income $107M, EPS $2.04
- Quarter ended May 31, 2022: revenue $1.57B (up 14.5% year over year), net income $113M, EPS $2.14
- Quarter ended Feb 28, 2022: revenue $1.54B (up 13.5% year over year), net income $110M, EPS $2.09
- Quarter ended Nov 30, 2021 (from the annual report): revenue $1.47B, net income $124M, EPS $2.36
CNXC cash flow, buybacks and dividends
- Fiscal year ended Nov 2025: operating cash flow $807M, share buybacks $169M
- Fiscal year ended Nov 2024: operating cash flow $667M, share buybacks $136M
- Fiscal year ended Nov 2023: operating cash flow $678M, share buybacks $64.0M
- Fiscal year ended Nov 2022: operating cash flow $601M, share buybacks $121M
- Fiscal year ended Nov 2021: operating cash flow $514M, share buybacks $25.1M
CNXC balance sheet
- Aug 31, 2026: cash $245M, total assets $9.26B, total liabilities $7.49B, shareholders' equity $1.77B, long-term debt $3.93B
- May 31, 2026: cash $256M, total assets $10.5B, total liabilities $7.81B, shareholders' equity $2.70B, long-term debt $3.93B
- Feb 28, 2026: cash $223M, total assets $10.7B, total liabilities $7.89B, shareholders' equity $2.79B, long-term debt $4.00B
- Nov 30, 2025: cash $327M, total assets $10.8B, total liabilities $8.02B, shareholders' equity $2.74B, long-term debt $4.57B
- Aug 31, 2025: cash $350M, total assets $12.4B, total liabilities $8.07B, shareholders' equity $4.34B, long-term debt $4.79B
- May 31, 2025: cash $343M, total assets $12.4B, total liabilities $8.12B, shareholders' equity $4.28B, long-term debt $4.86B
- Feb 28, 2025: cash $308M, total assets $11.9B, total liabilities $7.86B, shareholders' equity $4.03B, long-term debt $4.90B
- Nov 30, 2024: cash $241M, total assets $12.0B, total liabilities $7.95B, shareholders' equity $4.04B, long-term debt $4.73B
What is CNXC's revenue?
CONCENTRIX CORP reported $9.97B of revenue over its last four quarters, through August 31, 2026.
Is CNXC profitable?
No. CONCENTRIX CORP lost $2.39B over the last four quarters.
What is CNXC's EPS?
Diluted earnings per share over the last four quarters were −$38.42; −$16.24 in the latest quarter.